HS Code:
Cough drops, also known as throat lozenges, fall under the broader category of medicated confectionery or pharmaceutical preparations in global trade classifications. They are typically classified under HS Code 3004 (Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses). Cough drops are used to temporarily relieve symptoms of cough, sore throat, and minor mouth irritations. The global trade of cough drops is influenced by seasonal demand (e.g., flu seasons), consumer health trends, and the availability of herbal or natural alternatives. Major production hubs are often located in countries with strong pharmaceutical industries, while demand is widespread, particularly in regions with colder climates or high pollution levels.
Total Trade Volume
Approximately $1.2 billion USD
Data from 2022
Source
UN Comtrade Database and ITC Trade Map
$350 million USD
29.2% of total trade of total trade
Increasing
$200 million USD
16.7% of total trade of total trade
Stable
$150 million USD
12.5% of total trade of total trade
Increasing
$100 million USD
8.3% of total trade of total trade
Stable
$80 million USD
6.7% of total trade of total trade
Increasing
Average Rate
5.5% ad valorem
Highest Rate
12% (applied by certain developing countries to protect local industries)
Lowest Rate
0% (under free trade agreements like EU-USMCA or within WTO member states with specific exemptions)
Rising demand for natural and herbal cough drops
Increased market share for products with organic ingredients, driving innovation in formulations and marketing by major brands.
2021-2023
Growth in e-commerce sales channels
Online platforms have expanded access to cough drops, especially during pandemics, boosting trade volumes for smaller exporters.
2020-2022
Seasonal and pandemic-driven demand spikes
Higher imports during flu seasons and pandemics like COVID-19, with countries stockpiling essential health products.
2020-2023
The European Union introduced stricter import guidelines for medicated products, including cough drops, requiring detailed ingredient transparency and origin certification.
January 2023
Increased compliance costs for exporters to the EU, potentially reducing trade volumes from non-compliant countries.
A new bilateral agreement reduced tariffs on certain pharmaceutical products, including cough drops, to facilitate trade between the two countries.
March 2022
Boosted exports of US-made cough drops to China, contributing to market growth in Asia-Pacific.
India has seen a surge in local production of cough drops with herbal formulations, supported by government incentives for 'Make in India' initiatives.
October 2022
Reduced reliance on imports and increased export potential for Indian manufacturers, reshaping regional trade dynamics.